U.S. Medical Equipment Stock News

NYSE:VVV
NYSE:VVVSpecialty Retail

Valvoline (VVV) Stock Dips As Margin Pressure Tempers Strong Sales Growth

Valvoline stock is trading slightly lower today, down about 2% intraday, even though the quarter delivered exactly what this auto services story is built on. The headline is powerful for a maintenance chain. Net sales reached about US$545 million and adjusted EBITDA margin held close to 30%, with same store sales growth in the high single digits. The market seems more focused on the modest pullback in the share price than on a business that just converted higher tickets and traffic into solid...
NYSE:KD
NYSE:KDIT

Kyndryl (KD) Stock Ignores Quarterly Loss As Margin Turnaround Beckons

Kyndryl Holdings stock barely flinched after earnings, up about 1% in midday trading around US$14, even though the headline number was a fresh quarterly loss. The market seems willing to look past a Q1 FY2027 net loss of US$55 million and a free cash flow outflow of US$401 million because the longer story is about profitability potentially turning a corner. The real hook for long term investors is not this quarter’s red ink. It is management’s effort to lift thin margins through higher value...
NasdaqGS:CTSH
NasdaqGS:CTSHIT

Cognizant (CTSH) Stock Still Looks Undervalued As A 35% Run Tests Fair Value

Cognizant Technology Solutions stock has climbed 34.8% over the past month, yet its broader valuation checks still lean cheap relative to its fundamentals, which raises the question of how much upside the recent move has already priced in. The 34.8% gain over the past month signals a sharp shift in sentiment, which can quickly change how much of Cognizant Technology Solutions' long term potential is already reflected in the share price. Recent AI focused partnerships and expansion efforts...
NasdaqGS:DNLI
NasdaqGS:DNLIBiotechs

Denali Therapeutics (DNLI) Stock Could Be 20% Overvalued On Cash Flow Hopes

Denali Therapeutics stock has delivered a 70.2% return over the past year, yet the current checks suggest the market price sits at a premium to its intrinsic value estimate and to what broader valuation metrics would usually flag as a bargain. The 70.2% one year gain highlights how strongly sentiment has shifted in favor of Denali Therapeutics and raises the bar for what future progress needs to justify. Expectations around the company’s ability to convert its pipeline into sustainable cash...
NasdaqGS:LBTY.A
NasdaqGS:LBTY.ATelecom

Is Liberty Global (LBTY.A) Cheap Following Its Q2 2026 Earnings Update?

Liberty Global (LBTY.A) drew investor attention after reporting second quarter 2026 results that showed a much smaller net loss year on year, even as quarterly sales were slightly lower than the prior period. See our latest analysis for Liberty Global. Liberty Global’s latest results arrived after a mixed run for investors, with the share price down 13.85% over the past 90 days and the 1-year total shareholder return declining 4.17%, while the 3-year total shareholder return is positive at...
NYSE:RNST
NYSE:RNSTBanks

How Investors Are Reacting To Renasant (RNST) Surging Earnings, Lower Charge‑Offs And Buybacks

In the second quarter of 2026, Renasant Corporation reported net interest income of US$222.75 million and net income of US$87.09 million, while net loan charge-offs fell to US$2.77 million from US$12.05 million a year earlier. Together with completing US$148.92 million of share repurchases under its existing buyback program, these results point to stronger profitability and improved credit quality across the loan portfolio. With this backdrop of sharply higher earnings and lower charge-offs,...
NYSE:MTH
NYSE:MTHConsumer Durables

Is Softer 2026 Outlook And Ongoing Buybacks Altering The Investment Case For Meritage Homes (MTH)?

Meritage Homes Corporation recently reported past second-quarter 2026 results showing revenue of US$1,400.63 million and net income of US$90.63 million, both lower than the same period a year earlier, and issued updated full-year guidance calling for home closing volume and revenue to be around 5% below 2025 levels. At the same time, the company completed a sizeable share repurchase program totaling 12,237,123 shares for US$965.92 million since 2019, signaling continued use of buybacks even...
NYSE:MAC
NYSE:MACRetail REITs

Macerich (MAC) Stock Sees FFO Hold Up As Net Losses Persist

The market barely flinched at Macerich today. The stock slipped about 1% to US$25.39, a muted response for a retail REIT that just put a very specific tension on display between cash flow strength and accounting losses. The headline is simple. Second quarter funds from operations, the key profit yardstick for REITs, landed at about US$0.35 per share, while go forward portfolio net operating income grew in the low single digits. Yet Macerich again reported a quarterly net loss. That mix is...
NYSE:FBP
NYSE:FBPBanks

First BanCorp (FBP) Stock Looks About Right With Earnings In Focus

First BanCorp stock has delivered strong returns for long term holders over the past five years, yet the current valuation picture points to a company that now looks closer to fairly priced than clearly cheap. First BanCorp has returned 165.4% over five years, which sets a high bar for any further upside to be justified by fundamentals. The valuation now leans heavily on the bank's ability to sustain earnings quality and asset performance, while any weakening in credit trends or funding...